Gleason Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6K Buy
165
+1
+0.6% +$95 ﹤0.01% 179
2026
Q2
$13.9K Sell
164
-99
-38% -$7.98K ﹤0.01% 199
2026
Q1
$18.6K Buy
263
+101
+62% +$7.56K ﹤0.01% 155
2025
Q4
$12.8K Buy
162
+1
+0.6% +$79 ﹤0.01% 169
2025
Q3
$13.2K Sell
161
-25
-13% -$1.97K ﹤0.01% 156
2025
Q2
$14.9K Buy
186
+2
+1% +$154 ﹤0.01% 155
2025
Q1
$14.8K Buy
184
+1
+0.5% +$83 ﹤0.01% 153
2024
Q4
$15K Buy
+183
New +$15.2K ﹤0.01% 153

Other funds holding MET

Gleason Group's MET Position: Q3 2026 in Review

Gleason Group increased its MetLife (MET) stake by 0.61% in Q3 2026, buying an estimated $95 and bringing the position to 165 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

Gleason Group first reported a position in MET in Q4 2024 and has held it in 8 quarters since. The position peaked at $18.6K in Q1 2026. 175 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Gleason Group held 165 shares of MetLife worth $15.6K as of Q3 2026.
  • Gleason Group bought 1 MetLife share in Q3 2026, an estimated $95.
  • MetLife made up ﹤0.01% of Gleason Group's portfolio in Q3 2026, its #179 holding.
  • Gleason Group first reported a position in MetLife in Q4 2024 and has held it in 8 quarters since.
  • Gleason Group's MetLife position peaked at $18.6K in Q1 2026.
  • 175 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Gleason Group's 13F filing for Q3 2026, filed 15 Oct 2026.